Form EFFECT Aegerion Pharmaceuticals
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | June 10, 2016 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Possibilities' Premieres June 27, Reimagining Accessible Filmmaking Through Collaboration Between Blind, Low-Vision, and Sighted Creatives
- Beazer Homes Announces Closing of Offering of $400 Million Senior Unsecured Notes due 2032
- MFS Releases Closed-End Fund Income Distribution Sources for Two Funds
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
